|
|
||||||||
J Thorac Cardiovasc Surg 2002;124:371-376
© 2002 The American Association for Thoracic Surgery
Cardiopulmonary Support and Physiology (CSP) |
From the Division of Cardiothoracic Surgerya and the Department of Physiology and Biophysics,b The Institute for Molecular Cardiology, State University of New York at Stony Brook, Stony Brook, NY.
Received for publication Oct 10, 2001. Revisions requested Nov 8, 2001; revisions received Feb 8, 2002. Accepted for publication Feb 18, 2002. Address for reprints: Adam E. Saltman, MD, PhD, Division of Cardiothoracic Surgery, State University of New York at Stony Brook, Health Sciences Center T19-080, Stony Brook, NY 11794-8191 (E-mail: adam.saltman{at}sunysb.edu).
Background: Many stimuli can successfully protect the heart against ischemia. We investigated whether gap junction uncoupling before ischemia was myoprotective. We also studied the function of the adenosine triphosphate-dependent potassium channel, which has been implicated in the mechanism of pharmacologic preconditioning, with respect to gap junction physiology.
Methods: Twenty-eight rabbit hearts were placed on a Langendorff perfusion apparatus. Five were given a 5-minute infusion of 1 mmol/L heptanol (a gap junction uncoupler), 5 were given 10 µmol/L 2,3-butanedione monoxime (an electromechanical uncoupler), and 6 were given no drug. The left anterior descending coronary artery was then occluded for 1 hour and reperfused for 2 hours. Six hearts received 10 µmol/L glybenclamide before heptanol to evaluate the role of the adenosine triphosphate-dependent potassium channel. Six hearts underwent ischemic preconditioning with 2 cycles of 5 minutes of global ischemia and reperfusion. Action-potential duration of the ischemic zone, left ventricular developed pressure, and coronary flow were measured continuously. Infarct size was determined at the end of reperfusion.
Results: Heptanol significantly reduced infarct size (from 46% ± 2% to 22% ± 5%, P < .01), an effect that was not prevented by glybenclamide. Butanedione monoxime decreased developed pressure but did not significantly reduce infarct size (46% ± 5% vs 46% ± 2%, P = not significant). There were no differences among groups with regard to developed pressure or action-potential duration.
Conclusion: Directly blocking gap junctions preconditions the heart. This protection is not a direct result of a decrease in developed pressure before a prolonged ischemic period nor is it achieved through a mechanism involving the adenosine triphosphate-dependent potassium channel.
This article has been cited by other articles:
![]() |
R. Papp, M. Gonczi, M. Kovacs, G. Seprenyi, and A. Vegh Gap junctional uncoupling plays a trigger role in the antiarrhythmic effect of ischaemic preconditioning Cardiovasc Res, June 1, 2007; 74(3): 396 - 405. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yu, C. A. Bippes, G. M. Hand, D. J. Muller, and G. E. Sosinsky Aminosulfonate Modulated pH-induced Conformational Changes in Connexin26 Hemichannels J. Biol. Chem., March 23, 2007; 282(12): 8895 - 8904. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Hennan, R. E. Swillo, G. A. Morgan, J. C. Keith Jr., R. G. Schaub, R. P. Smith, H. S. Feldman, K. Haugan, J. Kantrowitz, P. J. Wang, et al. Rotigaptide (ZP123) Prevents Spontaneous Ventricular Arrhythmias and Reduces Infarct Size During Myocardial Ischemia/Reperfusion Injury in Open-Chest Dogs J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 236 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rodriguez-Sinovas, D. Garcia-Dorado, M. Ruiz-Meana, and J. Soler-Soler Protective effect of gap junction uncouplers given during hypoxia against reoxygenation injury in isolated rat hearts Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H648 - H656. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Przyklenk, M. Maynard, C. E. Darling, and P. Whittaker Pretreatment with D-myo-Inositol Trisphosphate Reduces Infarct Size in Rabbit Hearts: Role of Inositol Trisphosphate Receptors and Gap Junctions in Triggering Protection J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1386 - 1392. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Nguyen, L. J. Takemoto, and D. J. Takemoto Inhibition of Gap Junction Activity through the Release of the C1B Domain of Protein Kinase C{gamma} (PKC{gamma}) from 14-3-3: IDENTIFICATION OF PKC{gamma}-BINDING SITES J. Biol. Chem., December 10, 2004; 279(50): 52714 - 52725. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rodriguez-Sinovas, D. Garcia-Dorado, M. Ruiz-Meana, and J. Soler-Soler Enhanced effect of gap junction uncouplers on macroscopic electrical properties of reperfused myocardium J. Physiol., August 15, 2004; 559(1): 245 - 257. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R de Groot and R. Coronel Acute ischemia-induced gap junctional uncoupling and arrhythmogenesis Cardiovasc Res, May 1, 2004; 62(2): 323 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Camelliti, G. P Devlin, K. G Matthews, P. Kohl, and C. R Green Spatially and temporally distinct expression of fibroblast connexins after sheep ventricular infarction Cardiovasc Res, May 1, 2004; 62(2): 415 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. YELLON and J. M. DOWNEY Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology Physiol Rev, October 1, 2003; 83(4): 1113 - 1151. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |